Episode
16) Thomas Graf - The future of personalised cancer treatment and the role of basic research in the Covid19 response
- Published
- Mar 20, 2026
- Duration seconds
- 1368
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-european-molecular-biology-laboratory-embl-alumni-chats-series-7525543/episodes/16-thomas-graf-the-future-of-personalised-cancer-treatment-and-the-role-of-basic-research-in-the-covid19-response/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-european-molecular-biology-laboratory-embl-alumni-chats-series-7525543/16-thomas-graf-the-future-of-personalised-cancer-treatment-and-the-role-of-basic-research-in-the-covid19-response.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Thomas Graf (EMBL Head of Unit, 1983-1998) speaks with Angus Lamond (EMBL Group Leader, 1987-1995) about the potential of personalised cancer treatment, the role of basic research in the Covid-19 response and advice for young scientists. This interview was recorded in July 2022 Alumni Chat contributors are members of the European Molecular Biology Laboratory (EMBL) community. The opinions expressed are their own and are not necessarily representative of the views of EMBL or any other party. The mere appearance of content on EMBL Alumni media accounts does not constitute an endorsement by EMBL. Production and Editing: EMBL Alumni Relations Content and Interviews: Angus Lamond and Thomas Vaccari Music: Eco Technology by Aleksey Chistilin from Pixabay Thanks to: EMBL Audiovisual and EMBL Design Sponsored by: EMBLEM © European Molecular Biology Laboratory (EMBL)